Breast cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for about 30% (or 1 in 3) of all new female cancers each year. The American Cancer Society's ...

Doctors have been sounding the alarm over the colon cancer epidemic among young people-but experts now say there is another ...

Doctors have warned that cases of an extremely rare cancer are shooting up with symptoms often mistaken for a common illness ...

Doctors have been sounding the alarm over the colon cancer epidemic among young people-but experts now say there is another ...

The combination of trastuzumab deruxtecan (Enhertu) with pertuzumab (Perjeta) as a first-line treatment for HER2-positive advanced metastatic breast cancer has been shown to reduce the risk for ...

According to Rachael A. Safyan, MD, medical director of the Fred Hutch/UW Medicine HAI Pump Program, HAI is primarily for patients with metastatic colorectal cancer that has spread to the liver. Early ...

The ShorTrip trial found that short-course radiotherapy followed by FOLFOX and FOLFOXIRI improved pathological response rates in locally advanced rectal cancer. Patients with medium to high locally ...

31,515 people played the daily Crossword recently. Can you solve it faster than others?31,515 people played the daily Crossword recently. Can you solve it faster than others?

He created a Stanford course centered around his cancer journey, giving medical students an unfiltered view of terminal illness from a patient's perspective. "I have stage four lung cancer ...

Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an area of oncology that seeks to harness the immune ...